重度抑郁症psilocybin辅助治疗的成本效益:来自决策分析模型的探索性发现
Paul McCrone1, Henry Fisher2, Clare Knight2
1Institute for Lifecourse Development, University of Greenwich, London, UK.
Psychological medicine
|June 2, 2023
概括
松素辅助心理治疗 (PAP) 显示了严重抑郁症的潜在成本效益,特别是在降低药物价格和支持成本的情况下. 需要对长期结果进行进一步的研究来确认其价值.
科学领域:
- 心理药理学 心理药理学
- 卫生经济学 卫生经济学
- 心理健康治疗 心理健康治疗
背景情况:
- 越来越多的证据支持治疗耐药性抑郁症的 псилоцибин.
- 松素辅助心理治疗 (PAP) 是一种新兴的治疗方法.
- 对于 PAP 的比较性成本效益数据有限.
研究的目的:
- 为了比较PAP与重度抑郁症常规治疗的成本效益.
- 在6个月的时间内评估医疗保健和社会成本以及质量调整寿命年 (QALYs).
- 确定影响PPP成本效益的因素.
主要方法:
- 一个决策分析模型模拟了患者的结果 (反应,缓解,复发).
- 关于概率,成本和QALY的数据来源于现有的文献和专家估计.
- 进行了灵敏度分析,以评估参数不确定性.
主要成果:
- PAP的成本在6132英到7652英之间,高于传统药物治疗 (3528英),认知治疗 (4250英) 或组合治疗 (4197英).
- 与单独CBT (0.283),单独药物治疗 (0.278) 和组合治疗 (0.287) 相比,PAP产生了最高的QALY (0.310).
- 在特定条件下,psilocybin 证明了成本效益:治疗师支持成本减少 50%,psilocybin 价格在 400-800 英之间,改善了社会成本效益.
结论:
- 对严重抑郁症而言,松素治疗可能具有成本效益,这取决于药物的价格和心理支持水平.
- 优化PAP的成本效益需要仔细考虑治疗师的参与和药物支出.
- 长期结果数据对于全面的证据基础对西宾的治疗和经济价值至关重要.
相关概念视频
Electroconvulsive Therapy
83
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
83
Treatment Strategies for Psychological Disorders
178
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
178
Antidepressant Drugs: MAOIs and Other Agents
285
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
285
Modeling in Therapy
128
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
128
Psychosis: Goals of Pharmacotherapy
172
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
172
Depressive Disorders: MDD and Dysthymia
181
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
181


